combination therapy

January 26, 2021January 26, 2021

EPI-7386 Combo Therapies Enter Trial for Certain mCRPC Patients

News

Essa Pharma has entered a clinical collaboration with Janssen to evaluate its small molecule inhibitor EPI-7386, in combination with either Erleada (apalutamide) or Zytiga (abiraterone acetate) plus prednisone, for patients with ... Read more

March 9, 2020March 9, 2020

Prolaris Test Predicts Which PC Patients Benefit from Combo Therapy, Study Finds

News

Myriad Genetics’ Prolaris — a genetic test that predicts the aggressiveness of prostate cancer — can identify which men with intermediate or high-risk prostate cancer will benefit from combining androgen ... Read more

October 16, 2019October 25, 2019

Long-term Hormone Therapy Does More Harm than Good in Prostate Cancer Patients with Low PSA Levels After Surgery, Analysis Shows

News

Men who see their prostate cancer returning after surgery see no benefits from adding long-term hormone therapy to salvage radiation therapy if their PSA levels are low; instead, they might ... Read more

April 11, 2019

ADXS-PSA/Keytruda Combo Prolongs Survival in mCRPC, Early Trial Results Suggest

News

Adding ADXS-PSA, an investigational cancer vaccine, to Keytruda (pembrolizumab) is showing positive signs of safety and efficacy in patients with metastatic, castration-resistant prostate cancer (mCRPC), and appears to prolong survival ... Read more

November 3, 2017November 3, 2017

Packing Anti-cancer Agents within Albumin Boosts Combo Therapy Effectiveness Against Prostate Cancer, Study Shows

News

Combinations of certain anti-cancer therapies are more effective against castration-resistant prostate cancer if the drugs are packed within serum albumin, the most abundant protein in blood plasma, a new study ... Read more

September 12, 2017September 12, 2017

Two High-Risk Prostate Cancer Treatments Have Similar Benefits, Add-On Study Finds

News

Two treatment approaches — Zytiga (abiraterone acetate) plus prednisolone (AAP) or Taxotere (docetaxel) — provided patients with high-risk prostate cancer similar benefits when added to standard hormone deprivation therapy, according ... Read more